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ABSTRACT
Systemic inflammatory events and localized disease, mediated by the microbiome, 
may be measured in saliva as head and neck squamous cell carcinoma (HNSCC) 
diagnostic and prognostic biomonitors. We used a 16S rRNA V3-V5 marker gene 
approach to compare the saliva microbiome in DNA isolated from Oropharyngeal 
(OPSCC), Oral Cavity Squamous Cell Carcinoma (OCSCC) patients and normal 
epithelium controls, to characterize the HNSCC saliva microbiota and examine their 
abundance before and after surgical resection.
The analyses identified a predominance of Firmicutes, Proteobacteria and 
Bacteroidetes, with less frequent presence of Actinobacteria and Fusobacteria before 
surgery. At lower taxonomic levels, the most abundant genera were Streptococcus, 
Prevotella, Haemophilus, Lactobacillus and Veillonella, with lower numbers of 
Citrobacter and Neisseraceae genus Kingella. HNSCC patients had a significant loss 
in richness and diversity of microbiota species (p<0.05) compared to the controls. 
Overall, the Operational Taxonomic Units network shows that the relative abundance 
of OTU’s within genus Streptococcus, Dialister, and Veillonella can be used to 
discriminate tumor from control samples (p<0.05). Tumor samples lost Neisseria, 
Aggregatibacter (Proteobacteria), Haemophillus (Firmicutes) and Leptotrichia 
(Fusobacteria). Paired taxa within family Enterobacteriaceae, together with genus 
Oribacterium, distinguish OCSCC samples from OPSCC and normal samples (p<0.05). 
Similarly, only HPV positive samples have an abundance of genus Gemellaceae and 
Leuconostoc (p<0.05). Longitudinal analyses of samples taken before and after 
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surgery, revealed a reduction in the alpha diversity measure after surgery, together 
with an increase of this measure in patients that recurred (p<0.05). These results 
suggest that microbiota may be used as HNSCC diagnostic and prognostic biomonitors.
INTRODUCTION
Preliminary studies suggest that microbiota markers 
in saliva may be useful diagnostic and prognostic 
biomonitors for diverse health conditions [1-3]. Both 
systemic inflammatory events and localized disease, such 
as periodontal disease [4, 5] and head and neck squamous 
cell carcinoma (HNSCC) [6], may be mediated by the oral 
microbiome.
There were an estimated 300,400 newly diagnosed 
cases and 145,000 deaths from oral cavity cancer 
(including lip cancer) in 2012 worldwide. There were an 
estimated 86,700 new cases of nasopharyngeal carcinoma 
and 50,800 deaths in 2012 [7, 8]. A majority of HNSCC 
patients are diagnosed with tumors of the oral cavity 
(OSCC) and the oropharynx (OPSCC). It is estimated that, 
in 2015 alone, there will be approximately 45,780 new 
cases of cancer of the oral cavity and larynx and 8,650 
estimated deaths attributable to these cancers in the United 
States [8]. The major known etiological factors for oral and 
oropharyngeal cancer are smoking, alcohol consumption 
and high-risk human papilloma virus (HPV) infection. It 
is also known that the distribution and occurrence of oral 
cancer cases varies by age, ethnic group, culture, life-style, 
and level of country development [9]. For example, the 
Population Attributable Risk (PAR) due to the effects of 
tobacco and alcohol on oral cavity cancers is lower in the 
United States [10] than in Europe and Latin America [10]. 
However, the etiological role of bacteria in HNSCC has 
not been previously examined in detail [11].
The role of bacteria in the development of HNSCC 
cancer has not been delineated, but the persistent 
presence of bacteria at tumor sites in the oral cavity and 
oropharynx raises intriguing questions about the role of 
bacteria in the progression and treatment of HNSCC. 
Unfortunately, to date some studies have included only 
cultured oral bacterial species, using classical cloning and 
sequencing approaches [12, 13]. More recent studies of the 
oral microbiota have examined patients with OSCC and 
precancerous lesions, but they have been limited in scope 
and provide inconsistent results [14-16].
High-throughput technology for understanding the 
ecology of microbial ecosystems is increasingly being 
used to test hypotheses and build experimental strategies 
aimed at revealing the role of bacteria in health and 
disease [17]. The method of excellence for performing 
this characterization is the use of small-subunit ribosomal 
RNA (16S rRNA) studies, which bypasses the need for 
culturing. Instead, the 16S rRNA gene sequences (for 
archaea and bacteria) are used as stable phylogenetic 
markers to identify taxonomic lineages in a given sample 
[18, 19]. The 16S rRNA gene has nine variable regions: 
a combination of variable and moderately conserved 
regions is optimal for performing analyses at different 
phylogenetic depths, and the V3-V5 region is one of the 
preferred regions for characterizing the communities with 
few errors for taxonomy assignment [20-22].
Recent approaches using 454 parallel sequencing of 
the 16S rRNA were used to assess the diversity and relative 
abundance of bacteria in the saliva of OSCC patients and 
revealed a majority of Firmicutes and Bacteroidetes with 
only fifteen unique OTUs associated to OSCC patients [16, 
19]. The oral microbiome has previously been related to 
the establishment and progression of precancerous lesions 
and neoplasms in the oral cavity [23, 24]. In oral cancer 
samples from both a discovery and a validation cohort, 
abundance of Firmicutes (especially Streptococcus) and 
Actinobacteria (especially Rothia) was significantly 
decreased relative to anatomically matched contralateral 
normal samples after sequencing 16S rRNA hypervariable 
V4 region amplicons [14].
The significance of these cross-sectional findings 
is not yet clear. Furthermore, the microbial diversity 
and taxonomic composition of human oral microbiota 
associated with HPV positive and HPV negative tumors 
of the head and neck have not been examined and there 
have not yet been any attempts to examine the longitudinal 
associations between the microbiota in patients with 
cancer of the oral cavity and the oropharynx. Similarly, 
there have not been any longitudinal reports of the 
association between the pre- and post-treatment saliva 
microbiome of HNSCC.
We hypothesized that the microbiota provides a 
broad spectrum of taxa identification, a distinct sequence-
read record, and robust detection sensitivity, which can 
be used to develop saliva-based diagnostic tests of HPV 
positive and HPV negative, oral cavity and oropharyngeal 
cancer. In the present study, we did a cross-sectional 
comparison of the microbial communities present in 
saliva DNA from HPV positive and HPV negative patients 
with cancer of the oropharynx, cancer of the oral cavity, 
and normal oral cavity epithelium. We selected between 
1-4 additional saliva samples collected in subsequent 
visits, from 10 of the 19 HNSCC patients to evaluate 




This study was nested within a longitudinal 
cohort study of 787 patients who presented with 
histopathologically confirmed HSNCC (this includes 
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patients who presented for treatment of a recurrence after 
primary treatment at an outside hospital) to the outpatient 
clinic of the Johns Hopkins Hospital in Baltimore, 
Maryland from 2000 to 2011. Patients were included 
if they had at least one post-treatment salivary sample 
and consented for the study. All patients had undergone 
treatment with curative intent. The study protocol was 
approved by the institutional review board of the Johns 
Hopkins Hospital, as well as by the Johns Hopkins 
Institutional Review Board. Written informed consent was 
obtained from all patients.
Patients were consented for this study under the 
molecular surveillance clinical research protocol. Saliva 
was collected from 44 patients: 25 patients with no 
history of cancer and 19 HNSCC patients. Longitudinal 
saliva samples were collected from 58% of the HNSCC 
patients, totaling 62 samples. Nonetheless, we eliminated 
3 samples from 2 patients (2 OSCC and 1 OPSCC), 2 of 
them with unknown HPV status, as well as the only HPV 
positive OSCC sample. The analyses presented here are 
based on a total of 59 saliva samples acquired from 42 
patients; of these, 34 saliva samples corresponded to 17 
HNSCC patients and 25 saliva samples corresponded to 25 
controls without cancer, which also had negative smoking 
and drinking histories. Most of the HNSCC patients were 
OPSCC patients (7 were HPV positive and 4 were HPV 
negative), and the rest were OPSCC patients (all 6 were 
HPV negative) (Table 1).
Tissue and saliva samples were collected between 
2000 and 2011 and stored in the Johns Hopkins Head 
and Neck Cancer Research Division’s Tumor Bank, 
from where they were randomly selected for this study 
(Supplementary Table 1). Fifty-eight percent (58%) of 
the HNSCC patients chosen for the study had OPSCC. 
There was no difference in median age (66 and 62 years) 
or percentage of male patients (67% and 77%) between 
OSCC and OPSCC patients. Forty-seven percent (47%) 
of the HNSCC patients were HPV positive. Most HNSCC 
patients were former smokers or never smokers: OPSCC 
(72%) and OSCC (63%). Similarly, most HNSCC patients 
were occasional drinkers or non-drinkers: OPSCC (72%) 
and OSCC (63%). Approximately half of the patients were 
diagnosed with T1 or T2 stage tumors: OSCC (50%) and 
OPSCC (55%). Most patients had nodal involvement: 
OSCC (75%) and OPSCC (73%). None of the patients 
had known metastasis. All the OPSCC were treated with 
surgery and chemoradiation, compared to only 25% of the 
OSCC. Most of the OSCC patients (63%) only required 
surgical treatment (Supplementary Table 2).
We acquired a set of 607,646 raw reads when we 
sequenced the 16S rRNA V3–V5 hypervariable region 
from the 62 DNA samples used in the study. The number 
of sequences per sample ranged from 3,857 to 21,379 
and had an average of 9,645 sequences per sample 
(Supplementary Table 3). Sequences underwent strict 
quality and size filtering, removing reads shorter than 
150bp, as well as those with mismatches and poor quality 
scores. Sequences were then error-corrected using the 
Acacia tool, followed by de novo chimera detection with 
the UCHIME program, and screening for chloroplast 
contaminant sequences. In total, 490,169 sequences passed 
preprocessing. The 490,169 sequences were binned into 
8,771 OTUs. Control samples had the highest number 
of sequences and unique OTUs (197,743 and 13,849 
respectively) while squamous cell carcinoma samples 
varied from 125,608 to 78,330 sequences and 3,659 to 
2,924 OTUs respectively (Table 1).
Beta and alpha diversity analyses
Beta diversity comparisons using non-metric 
multidimensional scaling (NMDS), discriminated HNSCC 
from normal samples (Figure 1, panels A and B). The 
17 patient samples analyzed here corresponded only to 
the patient’s first visit only. Microbial communities in 
oropharyngeal cancer samples were clearly separated from 
normal samples and oral cavity cancer samples. A slight 
discrimination can be observed also according to HPV 
status. Analyses of beta dispersion showed significantly 
higher variance in the OPSCC samples as compared to 
the controls and OSCC HPV negative samples (p= 0.02).
We found a total of 13 assigned phyla present, 
with 5 of these dominating across all of the samples: 
Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, 
and Fusobacteria; with the other eight phyla having 
a relative abundance lower than 1%. In the control 
samples there was a dominance of Firmicutes (47.1%), 
Bacteroidetes (21.2%) and Proteobacteria (22.7%) while 
in the HNSCC samples the amount of Bacteroidetes 
(~13.4%) and Proteobacteria (~10.24%) decreased, 
and Firmicutes increased (~67%) (Figure 2A–2B). 
Overall, genus-level profiles showed a dominance of 
Streptococcus and Prevotella across all samples (Figure 
2C–2D). Lactobacillus OTUs were more dominant in 
HNSCC samples (9.1%) compared to the controls (0.1%). 
Neisseria had higher abundance in oral cavity HPV 
negative samples (4.66%) compared to oropharynx (~1%) 
and significantly more abundant than in the controls, while 
Citrobacter was more dominant in OPSCC HPV negative 
samples (6.2%). Haemophillus OTUs were dominant in 
all HPV negative samples (~4.1%) as compared to HPV 
positive (1%). Veillonella OTUs were more abundant in 
OPSCC HPV positive samples (15%) as compared to HPV 
negative samples (9.4%) (Figure 2D). Tables representing 
the relative abundance values for each of the control and 
tumor samples for all patients at the phyla and genus 
levels can be found in the supplementary material section 
(Supplementary Tables 4 and 5, respectively).
The OTU network shown in Figure 3A represents 
taxa that differed significantly in relative abundance 
(p<0.05) when comparing saliva from normal patients 
with patients with HNSCC, as well as HPV negative and 
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HPV positive patients (Supplementary Table 6). Overall, 
the network shows that the total abundance of genus 
Streptococcus, Dialister, and Veillonella can be used to 
discriminate tumor samples from control samples, which 
had close to half of their OTUs within genus Haemophilus, 
genus Neisseria and Leptotrichia (Figure 3B). 
Supplementary Figure 1A shows the significant difference 
in total abundance of Veillonella OTUs in HNSCC 
compared to normal. Supplementary Figure 1B shows 
the total abundance of significantly different Veillonella 
Figure 1: Beta diversity comparisons by Principal Component Analysis (PCA) using Non-metric multidimensional 
scaling (NMDS), with Euclidean distances, discriminated HNSCC (n=17) from Control samples (n=25). A. PCA reveals 
that the microbial communities in HNSCC patients are significantly different to those seen in Control samples. B. NMDS shows that the 
microbial communities in HPV negative (HPV-) oropharyngeal samples are significantly different from the ones seen in HPV- oral cavity 
patients.





Number of Patients Number of Samples Total Number of 
sequences















7 13 125,608 2,924
Oral Cavity Squamous 
cell carcinoma (OSCC) 
HPV Negative
6 10 78,330 3,659
Grand Total 42 59 496,017 23,734
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OTUs for each sample in the study, after subtraction of 
median total abundance of Veillonella OTUs from normal 
patients. Paired taxa within family Enterobacteriaceae 
together with genus Oribacterium, clearly distinguish 
OCSCC samples (Figure 3C), from OPSCC (Figure 3D 
and 3e) and normal samples. Similarly, only HPV positive 
samples have an abundance of genus Gemellaceae and 
Leuconostoc (Figure 3E).
To better understand the OTU diversity in our 
cohorts, we compared the alpha rarefaction curves 
between normal and HNSCC sample categories according 
to the Chao 1 richness estimator and Faith’s Phylogenetic 
Diversity index (see methods). Microbial communities 
from control samples display significantly higher richness 
(p<0.001) and significant higher diversity (p<0.001) than 
HNSCC samples (Figure 4A–4B). When considering HPV 
status and both sampling sites, we found that oral cavity 
(HPV negative) had a higher richness and diversity than 
oropharynx HPV positive (p<0.01) and negative (p<0.01) 
samples (Figure 4C–4D).
We also found significant differences in total 
abundance of Streptococcus spp. and Lactobacillus spp. 
OTUs in HNSCC samples when compared to control 
samples (p<0.05), using log-likelihood ratio tests and 
ANOVA in Qiime to compare the frequency of the 
OTUs. (Figure 5A) The taxonomic heatmap using 
Spearman’s distance, combined with Ward clustering of 
statistically significant OTUs between control and tumor 
samples, revealed that Streptococcus and Lactobacillus 
spp. are significantly associated with HNSCC samples 
(p<0.05) (Figure 5B). The abundance of Streptococcus, 
Peptostreptococcus and Tanerella was significantly 
higher in the tumor samples compared to the controls. 
Control samples had significantly more abundance of 
Agregatibacter, Lautropia, Haemophillus, Neisseria 
and Leptotricha, taxa that were nearly lost in the tumor 
samples.
We used linear discriminant analysis (LDA) of 
effect size (LEfSe) to determine the taxa that most likely 
explains the differences between tumor and control 
samples. We compared taxa, not only on the basis of 
statistical significance, but also taking into account 
biological consistency of the results and effect relevance, 
to predict the best biomarker for each category. Significant 
differences were found between saliva microbiota 
from normal and HNSCC patients, as well as between 
HPV positive and HPV negative patients. These results 
confirmed the significant enrichment of Lactobacillus 
and Streptococcus in HNSCC, and additionally found an 
enrichment of Staphyloccus and Parvimonas compared to 
the controls (Figure 6A). We also found that Haemopilus, 
Neisseria, Gemellaceae or Aggregatibacter are more 
abundant in saliva from normal patients compared to 
HNSCC patients. Similarly, we found a profusion of 
Lactobacillus and Weeksellaceae OTUs in HPV positive 
samples, and an abundance of Eikenella, Neisseria, and 
Figure 2: Taxonomic profiles at the phyla and genus levels, of 59 saliva samples according to tumor histology, HPV 
status and sampling site. There were a total of 13 microbial communities identified at the phyla-level in our patient population A. The 
top 5 (>1% relative abundance) communities were, Firmicutes, Bacteroidetes, Proteobacteria, Actinoabcteria and Fusobacteria B. At the 
genus-level, Streptococcus spp. prevail across all samples, followed by Veillonella, Prevotella, Lactobacillus and Haemophilus spp C-D.
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Figure 3: Nodes in Operational Taxonomic Units (OTUs) network significantly discriminate between head and neck 
squamous cell carcinoma (HNSCC) and normal samples in saliva. The figure was created using QIIME and imported to 
Cytoscape. Significant OTUs p< 0.05 were plotted in the OTU Network. Pie charts were created showcasing taxa distinguishing samples 
by Tumor Histology and HPV status. A. represents taxa that differed significantly in relative abundance (p<0.05) when comparing saliva 
from normal patients with patients with HNSCC, as well as HPV negative and HPV positive patients. The OTU network shows that the total 
abundance of genus Streptococcus, Dialister, and Veillonella can be used to discriminate tumor samples from control samples B. Paired 
taxa within family Enterobacteriaceae together with genus Oribacterium, clearly distinguish OCSCC samples C. Paired taxa within family 
Enterobacteriaceae together with genus Oribacterium, clearly distinguish OCSCC samples (from OPSCC and normal samples D. and E.. 





Leptotrichia OTUs in HPV negative patients (Figure 
6B). We also found significant pre-treatment differences 
in saliva microbiota from patients only treated with 
surgery, to patients treated with chemo-radiation therapy 
and surgery (CRT/Surgery). Patients treated with surgery 
had significant enrichment for Haemopilus, Neisseria, 
Aggregatibacter and Leptotrichia, while patients treated 
with CRT/Surgery had significant enrichment for 
Lactobacillus and Lactobacillaceae (Figure 6C).
Longitudinal analyses of selected samples
We collected longitudinal post-treatment samples 
from a subset of 11 patients. We had two samples collected 
from six patients, three samples collected from three 
patients and four samples collected from four patients. The 
interval between sample collections ranged widely from 2 
to 99 weeks, with a mean of 25.4 weeks, a median of 16.5 
weeks and interquartile range of 25.4 weeks. Repeated 
samples were analyzed according to the type of treatment, 
HPV status and TNM staging based on relative abundance 
of OTUs.
We found that community structure fluctuated 
by patient, but not significantly across all patients. We 
did not observe significant longitudinal associations 
between community profiling and HPV status or TNM 
stage, probably due to small sample size and the wide 
range of intervals between repeated sampling. We 
Figure 4: Rarefaction curves of species richness and diversity between Controls and HNSCC samples based on chao1 
richness estimator and Faith’s diversity measure (PD). Next-generation sequencing (NGS) has revealed a large microbial diversity 
that was previously concealed with culture-dependent methods. Although the true microbial diversity is limited to the number of samples, 
species richness and sample diversity can be estimated using diversity indices and species richness estimators. The chao1 index estimates 
total species richness based on all species actually discovered, including species not present in any sample. This approach uses the numbers 
of singletons (single appearance) and doubletons (that appeared twice) to estimate the number of missing species due to undetected species 
information is mostly concentrated on low frequency counts. Faith’s phylogenetic diversity (PD) measure estimates the relative feature 
diversity of any nominated set of species by the sum of the lengths of all phylogenetic branches required to span a given set of taxa on the 
phylogenetic tree. A. shows the chao1 index estimates when comparing tumor versus control. B. shows the PD estimates when comparing 
tumor versus control. C. shows the chao1 index estimates when comparing tumor site and HPV status. D. shows the PD estimates when 
comparing tumor site and HPV status. Microbial communities of samples obtained from Control patients display significant higher richness 
(p=0.001, ANOVA) and significant higher diversity (p=0.001, ANOVA) than HNSCC samples. When considering HPV status and both 
sampling sites we found that the diversity from the oral cavity (HPV negative) HNSCC samples was higher than in both HPV positive 
(p=0.003, ANOVA) and negative (p=0.006, ANOVA) HNSCC samples from the oropharynx.
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did observe that while each patient had differentially 
abundant taxa between each time point, compared to each 
other overall, there was a decrease in Streptococcus as 
TNM stage progressed. Simultaneously, Lactobacillus 
OTUs increased in higher TNM stage categories across 
all patients (p<0.05). Although sample size is small to 
confirm any direct changes upon intervention, we found 
the increase in Lactobacillus post treatment to have 
occurred in 6 out of the 10 patients (patients # 19, 12, 
13, 6 8 and 1). Veillonella increased in abundance after 
treatment in 73% of the patients. In fact, the patients with 
negative HPV results in salivary rinses, after initial HPV 
positive results before treatment, patients 1 and 12, had 
an increased dominance of Lactobacillus and a reduction 
in Prevotella. Overall fluctuations also occurred in the 
abundance of Veillonella, Prevotela and Streptococcus, 
when HPV status changed. A loss of HPV in the first 
patient resulted in a significant loss of Lactobacillus and 
increase in Streptococcus (Figure 7).
DISCUSSION
The human ‘metagenome’ is a composite of Homo 
sapiens genes and genes present in the genomes of the 
trillions of microbes that colonize the adult body [25]. 
Genes from the latter are thought to outnumber the former 
by several orders of magnitude. The microbial genomes 
(the microbiome) encode metabolic capacities that we 
have not had to evolve wholly on our own, but remain 
largely unexplored [26, 27].
To our knowledge this is the first report that 
examines the saliva microbiome of OPSCC and the 
longitudinal changes observed in pre-treatment and post-
treatment saliva microbiota. Several groups report high 
levels of colonization by microbiota in OSCC [12, 14, 
28]. Microbiota colonization of OSCC tumors, bacterial 
translocation to the cervical lymph nodes and subsequent 
postoperative infection occurs in patients with oral cancer 
[29, 30]. Dozens of oral Treponema strains can be isolated 
from subgingival plaque samples found in patients with 
periodontitis [31]. S. anginosus thought to exist in the 
mouth as a normal flora, and to be located mainly in 
the gingiva and dental plaque, can also be located in the 
tumor, suggesting it is implicated in the carcinogenesis 
of head and neck squamous cell carcinoma [32]. More 
recently, viable bacteria, mostly saccharolytic and aciduric 
species [33], have been isolated from both superficial 
and deep tissue sections of OSCC [34], revealing that 
the tumor microenvironment is well suited for bacterial 
survival.
This study sheds light on the association of 
microorganisms with HNSCC cancer, which has not yet 
been adequately examined. We have shown that HNSCC 
cancer samples have decreased richness and diversity 
Figure 5: Differentially enriched microbiota OTUs in HNSCC when compared to control samples. A. Histograms of the 
42 statistically significant differences between OTUs abundance show a significant abundance of Streptococcus spp. in HNSCC samples 
according to G-tests results (p<0.05) By default, OTUs unclassified at the genus level are plotted as N/A by Phyloseq. B. Taxonomic 
Heatmap using Spearman’s distance, combined with Ward clustering for 30 most statistically significant OTUs between Control and 
HNSCC samples (p<0.05, ANOVA). Heatmap color pallete used was “RdBu” with red and blue representing respectively low and high 
abundance. Ward’s clustering method involves an agglomerative clustering algorithm that treats a cluster analysis as an analysis of variance, 
used to analyze the differences among group means and their associated classes. Streptococcus and Lactobacillus spp. are significantly 
associated with HNSCC samples according to G-tests and ANOVA results.
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compared to controls although there are very few OTUs 
that change according to HPV status. Nonetheless, we 
found an interesting association of Lactobacillus OTUs 
with HNSCC cancer and HPV negative samples and a 
loss of Prevotella compared to the controls. This is the 
first report of Lactobacillus being significantly associated 
with HNSCC cancer samples, although these have been 
reported as major causes of caries, hyposalivation or 
xerostomia as well as in deep dentinal caries associated 
with pulpitis in adults [35]. We found an evident 
association of Lactobacillus OTUs with tumor samples. 
In patients from whom we had collected saliva samples 
at different time points, the abundance of Lactobacillus 
increased with advanced TNM stage. We also report that 
Neisseria is an abundant member of the oral cavity flora as 
it is significantly more abundant in HPV negative controls. 
Despite the fact that Neisseria are gram-negative taxa, 
certain OTUs seem to have been exploited for the design 
of vaccines comprising N. lactamica-derived antigens, 
e.g., outer membrane vesicles (OMVs) [36, 37].
Significant differences in microbiota were also 
found when the linear discriminant analysis for effect size 
(LEfSe) algorithm was used on genus level OTU tables to 
determine taxa that best characterize each biological class, 
when comparing HNSCC from normal and HPV positive 
from HPV negative samples. LEfSe identifies features 
that are statistically different among biological classes 
(Kruskal-Wallis sum-rank test, p<0.05). It then performs 
Figure 6: LDA Effect Size (LEfSe) algorithm was used on genus level OTU tables to determine taxa that best 
characterize each biological class: A. Comparison of HNSCC with normal samples found that Streptococcus and 
Lactobacillus spp. are significantly associated with HNSCC samples. Haemophilus and Neisseria spp. are related to Control samples. 
B. Comparison of HPV positive and HPV negative HNSCC found that Lactobacillus spp. is significantly associated with HPV positive 
samples in the oropharynx. Similarly, Eikenella and Neisseria spp. are associated with HPV negative samples. Patients treated with surgery 
had significant enrichment for Haemopilus, Neisseria, Aggregatibacter and Leptotrichia, while patients treated with CRT/Surgery had 
significant enrichment for Lactobacillus and Lactobacillaceae C.
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additional tests to assess whether these differences are 
consistent with respect to expected biological behavior 
(Wilcoxon ran-sum test, p<0.05). Lastly, effect relevance 
is estimated by the linear discriminant analysis (LDA) 
effect size. LEfSe analysis confirmed the significant 
enrichment of Lactobacillus and Streptococcus in the 
HNSCC tumors found by OTU analysis with G-test 
and ANOVA, and additionally found an enrichment of 
Staphylococcus and Parvimonas compared to controls. 
In addition, we found that Haemopilus, Neisseria, 
Gemellaceae and Aggregatibacter are more abundant 
in controls, compared to the tumor samples. Similarly, 
we found an enrichment of certain Lactobacillus and 
Weeksellaceae in the HPV positive samples, and an 
abundance of Eikenella, Neisseria, and Leptotrichia in the 
HPV negative tumors used, when we used LefSe analyses 
to compare HPV positive and negative tumor samples.
Together this data suggests that the enriched 
presence of Lactobacillus, or the loss of Haemopilus, 
Neisseria, Gemellaceae or Aggregatibacter in saliva 
may be biomarkers of HNSCC cancer. We have also 
demonstrated that potential biomarkers for HPV+ 
HNSCC tumors include Veillonella, Megasphaera and 
Anaerolineae, which are anaerobic, saccharolytic and 
acid tolerant taxa. This is in agreement with the fact that 
the microenvironment of solid tumors is typically hypoxic 
with low pH, thus favoring the growth of this taxa [38].
The reduction of Proteobacteria (in our study taxa 
such as Haemopilus or Neisseria) in the tumors compared 
to the controls, was also found in a recent study where 
Proteobacteria taxa at all phylogenetic levels decreased 
in recent smokers while Streptococcus and Atopobium 
increased [39]. In fact, similar findings were reached in 
a study comparing the microbiota coating the tongue as 
potential source for diagnosing gastric cancer, and found 
that Proteobacteria also decreased in the oral microbiota 
of gastric cancer patients [40]. Changes in the oral 
microbiome in tumors, compared to controls suggest that 
the oral community structure may result in changes in 
functional pathways with systemic relevance.
Microorganisms cause an estimated 20% of 
human cancer [41, 42]. The best know example is the 
role Helicobater pylori plays in gastric cancer [43-45]. 
However, a handful of laboratories have reported links 
between bacterial infection and oral [11], colon [46-
49], pancreatic [46, 50], liver [51], esophageal [52] and 
prostate cancers [53]. The biological mechanism of these 
associations is not yet understood [54, 55], however, 
there are several mechanisms by which bacterial infection 
could lead to the initiation and progression of oncogenic 
Figure 7: Time-series analyses of HNSCC patients (n=11) for whom we had repeated saliva samples, according to 
both sampling sites, HPV status and TNM staging. Bacterial communities were noticeably different between T1-2N2AM0 and 
T3N2BM0 TNM stage. Lactobacillus spp. were significantly more abundant in patients with T3-2N2BM0 staging (p<0.01, G-test). Legend 
indicates genus that show a relative abundance higher than 1%.
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processes [42, 56, 57]. Bacterial endotoxins, metabolic 
byproducts of bacterial infection, and increased enzymatic 
activity as a result of bacterial infection, can induce 
somatic mutations and signaling pathway alterations 
[58]. Furthermore, the inflammatory cells and cytokines 
found in the tumor microenvironment of bacterial related 
chronic inflammation can lead to the creation of reactive 
oxygen and nitrogen species, which can also induce DNA 
alterations [24, 59, 60].
It has recently been shown that commensal bacteria 
can potentiate the effect of immunotherapy with check-
point inhibitors. Oral administration of Bifidobacterium 
improved tumor control to the same degree as programmed 
cell death protein 1 ligand 1 (PD-L1)–specific antibody 
therapy, and combination treatment nearly abolished tumor 
outgrowth [61]. Similarly, the immunostimulatory impact 
of CTLA-4 blockade, leading to the antitumor effects, 
depends on distinct Bacteroides species. In mice and 
patients, T cell responses specific for B. thetaiotaomicron 
or B. fragilis are associated with the efficacy of CTLA-4 
blockade [62].
We provide intriguing and preliminary data that 
evaluates the salivary microbiome and its relationship to 
head and neck cancer, HPV status, and its treatment. The 
major limitation of the study is the limited sample size. We 
are the first to show evidence of a repopulation or shift of 
the microbial communities seen in HPV positive HNSCC 
after surgical treatment. Our preliminary results suggest 
that the microbial diversity and taxonomic composition of 
the microbiota in saliva may be useful diagnostic and early 
detection biomonitors for HNSCC [63]. Potentiation of 
immunotherapy by the microbiota represents an important 
new concept to help explain the heterogeneity of anti-
tumor immunity observed in the clinic. Although studies 
published today do not focus on microbiota specific to 
HNSCC, it seems very likely that the HNSCC microbiome 
could play similar roles as those shown in other tumors 
[64]. Further studies are needed to understand the 
etiologic role of the microbiome in HNSCC in general, 
and in OSCC and OPSCC specifically. Further studies are 
also needed to elucidate how specific microbiota affects 
immunotherapy. This is the first attempt at identifying taxa 
associated with HNSCC anatomic subsites, HPV status 
and surgical treatment status in pretreatment and post-
treatment salivary rinses. Future work will determine the 
correlation of microbial communities in paired tissue and 




Tumor samples and salivary rinses from 19 
HNSCC patients and 25 normal controls were obtained as 
previously described [65]. The oral rinses were performed 
with 20 mL of normal saline gargled twice, for 20 and 
10 seconds respectively. Pre-operative tumor and saliva 
specimens were collected prior to commencement of any 
therapy at the Johns Hopkins Hospital. In cases where 
fresh frozen tumor DNA was not available, archival 
paraffin embedded tissue sections were obtained and in 
situ hybridization was performed as described previously 
[66], to assess the initial HPV-16 status. In total, we 
analyzed 19 cases with matched pairs of tumor and pre-
treatment saliva DNA and 11 cases with tumor DNA, and 
both pre-treatment and from two to five post-treatment 
saliva DNA samples. Surveillance salivary rinses were 
obtained in the follow-up clinic visits from most of 
the HNSCC patients. Our protocol states that the first 
post-treatment rinse was collected 3 months after the 
completion of all treatment and then every 3 months for 
two years total. However, we were not able to obtain 
follow-up salivary rinses every three months for all 
patients so we included patients with at least one post-
treatment salivary sample in this analysis.
DNA extraction
Microdissected tissues and saliva (2mL) samples 
were centrifuged and the pellets were digested with 1% 
SDS and 50 μg/mL proteinase K (Boehringer, Mannheim, 
Germany) at 48°C overnight extracted with phenol/
chloroform, precipitated in 100% ethanol, centrifuged at 
5100 rpm for 45 minutes, washed in 70% ethanol twice, 
dissolved in LoTE buffer (10mM TRIS hydrochloride, 
1mM EDTA buffer, pH 8), and stored at −20°C [67].
Quantitative PCR
The 7900HT real time PCR system was used 
to perform quantitative PCR for HPV-16 E6 and 
E7 and B-actin. Specific primers and probes have 
been designed to amplify the E6 and E7 regions 
of HPV type 16: HPV-16 E6 forward primer, 
5’-TCAGGACCCACAGGAGCG-3’; HPV-16 E6 reverse 
primer, 5’-CCTCACGTCGCAGTAACTGTTG-3’, HPV-16 
E6 TaqMan probe, 5’-(FAM)-CCCAGAAAGTTACCAC 
AGTTATGCACAGAGCT-(TAMRA)-3’, HPV-16 E7 
forward primer, 5’-CCGGACAGAGCCCATTACAA-3’, 
HPV-16 E7 reverse primer, 5’-CGAATGTCTACG 
TGTGTGCTTTG-3’, HPV-16 E7 TaqMan probe, 
5’-(FAM)-CGCACAACCGAAGCGTAGAGTCACACT-
(TAMRA)-3’. A housekeeping gene (B-globin) were run 
in parallel with HPV-16 E6 and E7 to standardize the 
input DNA: B-actin forward primer, 5’-TCACCCACA
CTGTGCCCATCTACGA-3’, B-actin reverse primer, 
5’-CAGCGGAACCGCTCATTGCCAATGG-3’, B-actin 
TaqMan probe, 5’-(FAM)-ATGCCCTCCCCCATGCCA 




The CaSki (American Type Culture Collection, 
Manassas, VA) cell line was used to develop standard 
curves for the HPV viral copy number as it is known to 
have 600 copies/genome equivalent. Standard curves 
for HPV-16 E6 and E7 were developed by using DNA 
extracted from CaSki cells, serially diluted into 50 ng, 
5 ng, 0.5 ng, 0.05 ng, and 0.005 ng. A standard curve 
was also developed for the housekeeping gene B-actin 
(2 copies/genome), using the same serial dilutions of 
CaSki DNA. Tumor samples with ≥ 0.1 copy/genome and 
salivary samples with > 0 copy/genome were considered as 
HPV positive. Simple sensitivity and specificity analyses 
were performed on the cases with local recurrence. No 
statistical correlation was attempted due to modest sample 
size.
Creation of the 16S rRNA V3-V5 amplicon 
library
An amplicon library from individual samples was 
created by PCR amplification with unique barcoded 
primers of the 16S rRNA V3-V5 gene region, using 
the 357F/926R primer set. We used 14 different 
barcode sequences and the linker primer sequence 
CCGTCAATTCMTTTRAGT to analyze the 16S rRNA 
V3–V5 hypervariable 16S rRNA gene region.
DNA sequencing and bioinformatics analyses
Sequencing of the multiplexed amplified 
fragments was performed on the Roche/454 GS Junior 
pyrosequencing platform. Bioinformatics preprocessing 
steps included quality filtering, error-correction, and 
chimera removal. Briefly, reads were de-multiplexed 
using 5’ barcodes, trimmed of forward and reverse primer 
sequences, filtered for length and quality, and corrected 
for homopolymer errors. High quality reads were selected 
for analysis and reads with unknown bases (“N”) were 
discarded. The resulting high-quality dataset was then 
screened for chimeric sequences and contaminant 
chloroplast DNA.
Passing sequences were characterized for diversity 
and taxonomic composition using the Quantitative Insights 
into Microbial Ecology (QIIME) suite, version 1.9 where 
all the beta and alpha diversity measure and significance 
tests were performed [68, 69]. To begin, sequences were 
clustered into operational taxonomic units (OTUs) using 
UCLUST with a 97% identity threshold. Taxonomic 
assignment was performed using the RDP classifier 
(trained by a customized version of the comprehensive 
GreenGenes database, release v.13-05) with a minimum 
confidence threshold of 0.80. After considering the raw 
count data in full above, subsample analysis of each 
community was performed to an equivalent depth, in this 
case, 3,400 sequences per sample. All results are based 
on the subsampled data, which mitigates biases due to 
differences in sampling depth.
An OTU network was generated using QIIME 
[69] and imported to Cytoscape [70] based on OTUs that 
changed significantly in abundance (p<0.05) as result of 
a maximum likelihood statistical significance tests. The 
selected OTUs were plotted choosing nodes from the OTU 
network and sorting edges interaction by the four different 
sample types: normal, HPV negative OSCC, HPV 
negative OPSCC and HPV positive OPSCC. Additionally, 
we represented the taxonomy of taxa at the genus-level 
through pie charts at each of the four sample types.
Statistical analysis
For each group comparison, significance tests were 
computed including the maximum likelihood statistical 
significance tests that determine whether OTU presence/
absence is associated with a category in the metadata. The 
goodness of fit or log-likelihood ratio parametric test (G-
test) compares the ratio of the observed OTU frequencies 
in the sample groups to the expected frequencies based 
on the null hypothesis (all sample groups have equal 
OTU frequencies). QIIME [69] was used to create all 
the heatmaps and estimate the following Alpha-diversity 
metrics: raw number of OTUs per sample, Chao1 
estimator, Shannon entropy, Non-Metric dimensional 
scaling, and Bray-Curtis distance metric.
The chao 1 index approach for richness was used 
because it uses the numbers of singletons (OTUs with 
single appearance) and doubletons (OTUs that appeared 
twice) to estimate the number of missing species because 
missing species information is mostly concentrated on 
low frequency counts. Faith’s phylogenetic diversity 
index (PD) estimates the relative feature diversity of any 
nominated set of species by the sum of the lengths of all 
phylogenetic branches required to span a given set of 
taxa on the phylogenetic tree. The relative group variance 
homogeneity was verified with the function ‘betadisper’ 
also in the “vegan” package. Richness box and whisker 
plots were calculated using both vegan [71] and Phyloseq 
[72] R packages.
We used linear discriminant analysis (LDA) 
with LefSe [73] an algorithm biomarker discovery that 
identifies taxa characterizing the differences between two 
metadata classes. It emphasizes statistical significance, 
biological consistency and effect relevance, allowing 
researchers to identify differentially abundant features that 
are also consistent with biologically meaningful categories 
(metadata), using non-parametric factorial Kruskal-Wallis 
(KW) sum-rank test, Wilcoxon rank-sum test and LDA. 
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